E. Phelps

发表

Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

C. Kelly, J. Marchesi, B. Mullish, 2020, Inflammatory bowel diseases.

Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?

Huiping Xu, B. Roach, D. Kao, 2019, Digestive Diseases and Sciences.

Fecal Microbiota Transplant Decreases Mortality in Patients With Refractory Severe and Severe Complicated Clostridium difficile Infection Not Eligible for Colectomy: 2017 Fellows-in-Training Award (Colon Category): 100

Huiping Xu, Z. Kassam, J. Allegretti, 2017 .

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

E. Petrof, Huiping Xu, T. Monaghan, 2019, Gut microbes.

Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience

Huiping Xu, D. Kao, Z. Kassam, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease

M. Mellow, D. Rex, H. Sokol, 2016, Inflammatory bowel diseases.

Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.

Huiping Xu, Z. Kassam, J. Allegretti, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach

Huiping Xu, Z. Kassam, B. Sipe, 2016, Gut microbes.

Fecal Microbiota Transplantation is Safe and Effective in Patients with Clostridioides difficile Infection and Cirrhosis.

A. Khoruts, G. Ianiro, Huiping Xu, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection

C. Kelly, J. Allegretti, J. Marcus, 2020, Journal of clinical gastroenterology.

Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.

Z. Kassam, J. Allegretti, M. Fischer, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Classifying Fecal Microbiota Transplantation Failure: An Observational Study Examining Timing and Characteristics of Fecal Microbiota Transplantation Failures

Huiping Xu, Z. Kassam, J. Allegretti, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study

C. Kelly, A. Keshteli, Huiping Xu, 2016, The American Journal of Gastroenterology.

Predictors of Failure After Fecal Microbiota Transplantation (FMT) for the Therapy of Clostridium difficile Infection (CDI): 1335

C. Kelly, Huiping Xu, B. Sipe, 2015 .

7 – The Icon Study: Inflammatory Bowel Disease and Recurrent Clostridium Difficile Infection: Outcomes After Fecal Microbiota Transplantation

C. Kelly, J. Marchesi, B. Mullish, 2019, Gastroenterology.